Pulmonology

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

Retrieved on: 
Monday, November 6, 2023
Oncology, Health, Health Technology, Clinical Trials, General Health, Biotechnology, Water, Pulmonology, Lymph, BIAF, Physician, Lung cancer, Organization, Emphysema, Quality of life, National Directorate of Intelligence and Prevention Services, Lung, Marketing, Hospital, Hygiene, Patient, Diagnosis, COPD, Bronchoscopic lung volume reduction, Medical imaging, Ecolab

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced the appointment of Dallas J. Coleman as National Director of Sales.

Key Points: 
  • bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced the appointment of Dallas J. Coleman as National Director of Sales.
  • Mr. Coleman has more than 15 years of experience in medical sales and marketing, most recently as Executive Account Manager for the respiratory portfolio of Olympus America’s therapeutic solutions division.
  • Reporting to bioAffinity Technologies President and Chief Executive Officer Maria Zannes, Mr. Coleman is responsible for leading the CyPath® Lung sales team and sourcing new business opportunities.
  • “We are delighted to welcome Dallas to our management team in this newly created position.

American Association for Respiratory Care Honors Tri-anim Health Services with 2023 Zenith Award

Retrieved on: 
Monday, October 30, 2023
Pulmonology, Customer, Anesthesiology, Health, Advertising, Caregiver, Hospital, AARC, Nursing, Anesthesia, American Association for Respiratory Care, Nursing care plan, Sarnov

DUBLIN, Ohio , Oct. 30, 2023 /PRNewswire/ -- Tri-anim Health Services, a Sarnova company and a leading distributor of specialized respiratory, anesthesia, and critical care supplies, services and equipment, has been honored with the prestigious 2023 Zenith Award by the American Association for Respiratory Care (AARC).

Key Points: 
  • DUBLIN, Ohio , Oct. 30, 2023 /PRNewswire/ -- Tri-anim Health Services, a Sarnova company and a leading distributor of specialized respiratory, anesthesia, and critical care supplies, services and equipment, has been honored with the prestigious 2023 Zenith Award by the American Association for Respiratory Care (AARC).
  • This marks the fifth time that Tri-anim has won the Zenith Award (2023, 2021, 2020, 2018, and 2017).
  • The AARC Zenith Award is the "people's choice" award of the respiratory care profession because its recipients are chosen and voted upon by caregivers – the respiratory therapists.
  • Since 1975, Tri-anim has served as a specialty healthcare consultant and distributor of respiratory care, anesthesia, critical care and neonatal care supplies and equipment.

ConcertAI's TeraRecon partners with Optellum to integrate AI-powered early lung cancer diagnosis and precision treatment planning

Retrieved on: 
Tuesday, October 17, 2023
Diagnosis, Algorithm, Lung cancer, Partnership, LCP, Natural language processing, Doctor of Philosophy, Research, NSCLC, Radiology, AI, Risk, Cardiology, Neurology, Pulmonology, FDA, ESMO, Oncology, Congress, Eureka, European Society for Medical Oncology, PACS, Patient, Medical device, Medical imaging

CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning.

Key Points: 
  • CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ -- ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning.
  • Lung cancer often shows no symptoms until a late stage when treatment options are more limited and outcomes less positive.
  • TeraRecon's collaboration with Optellum marks a significant milestone in advancing lung cancer diagnosis and aiding thoracic oncology teams in treatment," said Jeff Elton, PhD, CEO of ConcertAI.
  • In the ESMO scientific program, Optellum's clinical partners will present the first results towards extending the LCP platform into AI-guided precision treatment in the "NSCLC, Early Stage".

New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease

Retrieved on: 
Thursday, October 12, 2023
Health, Genetics, Clinical Trials, General Health, Cardiology, Biotechnology, Annual general meeting, Diagnosis, UIP, Physician, American College of Chest Physicians, Radiology, American College, ILD, Connective tissue, Idiopathic pulmonary fibrosis, HRCT, UCLA Health, CT, Vicki Belo, Interstitial lung disease, Scar, Disorder, Fibrosis, Patient, Medical imaging, Medical device, Pulmonology

(Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).

Key Points: 
  • (Nasdaq: VCYT) today announced that new data presented at the American College of Chest Physicians (CHEST) Annual Meeting 2023 demonstrate the clinical utility of the company’s Envisia Genomic Classifier, which is used by physicians to improve diagnostic and prognostic confidence of interstitial lung diseases (ILDs).
  • The studies also underscore the challenge of identifying usual interstitial pneumonia (UIP) in patients being evaluated for ILD.
  • The studies presented at the CHEST Annual Meeting show that adding the Envisia Genomic Classifier to the diagnostic process can improve the ability to detect UIP.
  • For patients with indeterminate HRCT results, adding the Envisia Genomic Classifier more than doubled the UIP diagnostic yield to 49%.

Pulmonary Fibrosis Foundation Names Dr. Franck Rahaghi New President, CEO and Chief Medical Officer

Retrieved on: 
Tuesday, September 5, 2023
San Francisco, Pulmonary fibrosis, Abstract, American College of Chest Physicians, Critical care, Cleveland Clinic, Health policy, University, Education, Internal medicine, Cystic Fibrosis Foundation, ILD, Alternative medicine degrees, Research, Weill Cornell Medical Center, American Thoracic Society, Biomedical engineering, Consultant, Clinical professor, Government, Pulmonology, San Diego, Pulmonary hypertension, MHS, Publication, Biomedicine, MD, Pulmonary Hypertension Association, Berkeley, University of Illinois Urbana-Champaign, FCCP, Rockcastle Regional Hospital and Respiratory Care Center, Nursing care plan, PFF, Health, CCN, Pharmaceutical industry, Nursing, Medicine

CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15. Following an extensive search, Dr. Rahaghi was selected based on his long-time commitment to care, research, and education in interstitial lung disease (ILD) and pulmonary fibrosis (PF). He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.

Key Points: 
  • CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15.
  • He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.
  • In 2003, he joined the medical center as Staff Attending in Pulmonary Critical Care and Director of the Pulmonary Hypertension Clinic.
  • Dr. Rahaghi succeeds Bill Schmidt, former President and CEO of the PFF, and Dr. Joseph Lasky, the Foundation's former Chief Medical Officer.

Noah Medical Unveils Preliminary First In-Human Trial Results to Standing-Room-Only Audience at AABIP 2023

Retrieved on: 
Wednesday, August 30, 2023
CT, Intervention, Workflow, Navigation, Macquarie University Hospital, GameChanger, Cancer, Pulmonology, Doctor of Philosophy, American College of Chest Physicians, Patient, Physician, Risk, SAN, Diagnosis, American College, FDA, Safety, Biopsy, Pharmaceutical industry, Nursing, Medical imaging, Galaxy

The data was presented at the American Association of Bronchology and Interventional Pulmonology’s annual conference ( AABIP 2023 ) in Chicago.

Key Points: 
  • The data was presented at the American Association of Bronchology and Interventional Pulmonology’s annual conference ( AABIP 2023 ) in Chicago.
  • “Noah Medical was founded with a patient and physician focus to solve the most complex and challenging gaps in early diagnosis and treatment.
  • Noah Medical received FDA clearance for the Galaxy System in March 2023.
  • To learn more about Noah Medical and the Galaxy System, please visit noahmed.com .

ConcertAI's TeraRecon Partners with Optellum to Integrate Virtual Nodule Clinic Solution into Eureka Clinical AI Platform

Retrieved on: 
Wednesday, August 23, 2023
Concert, Lung cancer, Research, Pulmonology, Radiology, Doctor of Philosophy, Algorithm, PACS, Diagnosis, AI, Oncology, Cardiology, Health, Neurology, Medical device, Medical imaging

Through this collaboration, Optellum's state-of-the-art Virtual Nodule Clinic solution will be seamlessly integrated into TeraRecon's Eureka Clinical AI platform.

Key Points: 
  • Through this collaboration, Optellum's state-of-the-art Virtual Nodule Clinic solution will be seamlessly integrated into TeraRecon's Eureka Clinical AI platform.
  • The integration the Virtual Nodule Clinic solution with the Eureka Clinical AI platform will empower radiologists and oncologists with advanced AI algorithms that help with accurate assessment, characterization, and management of lung nodules.
  • "The addition of the Virtual Nodule Clinic solution to ConcertAI's TeraRecon Eureka Clinical AI platform will assure customers state-of-the-art tools to assess and characterize lung nodules efficiently and accurately."
  • Eureka Clinical AI is the leading AI SaaS imaging interpretation and clinical decision augmentation solution from TeraRecon.

Theken Companies Acquires VisionAir Solutions

Retrieved on: 
Tuesday, August 22, 2023
Stent, Anatomy, FACP, Pulmonology, CAO, Acquisition, MD, Patient, Physician, Invention, FCCP, FDA, Medical imaging, Cleveland Clinic, Visionary

AKRON, Ohio, Aug. 22, 2023 /PRNewswire/ -- Theken Companies, an Akron, Ohio-based family of medical device companies, today announced its acquisition of VisionAir Solutions from Cleveland Clinic.

Key Points: 
  • Theken Companies announces its acquisition of VisionAir Solutions from Cleveland Clinic.
  • AKRON, Ohio, Aug. 22, 2023 /PRNewswire/ -- Theken Companies, an Akron, Ohio-based family of medical device companies, today announced its acquisition of VisionAir Solutions from Cleveland Clinic.
  • Randy Theken, Founder of Theken Companies, said of the acquisition, "I was truly overwhelmed by the technology created by the VisionAir team at Cleveland Clinic.
  • Thomas Gildea, MD, FCCP, FACP, of Cleveland Clinic and Inventor and Head of the Clinical Advisory Team at VisionAir Solutions, stated, "We are excited to collaborate with Randy Theken and the new VisionAir team.

The Inner Circle Acknowledges, Gary L. Berg as a Top Pinnacle Healthcare Professional for his contributions to the Pulmonology Field

Retrieved on: 
Monday, August 21, 2023
Bachelor, DOS, Des Moines University, Osteopathic medicine in the United States, Education, Internal medicine, Public, AOBIM, Respiratory system, Multimedia, American Osteopathic Association, AOA, Pulmonology, Inner circle, American Osteopathic Board of Internal Medicine, Organization, Public health, Physician, Michigan State University, Doctor of Osteopathic Medicine, Patient, Sleep, Ascension, Disease, Nursing, Microbiology

BLOOMFIELD HILLS, Mich., Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Gary L. Berg is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the Pulmonology Field.

Key Points: 
  • BLOOMFIELD HILLS, Mich., Aug. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Gary L. Berg is acknowledged as a Top Pinnacle Healthcare Professional for his contributions to the Pulmonology Field.
  • Dr. Berg pursued higher education at Michigan State University where he earned a Bachelor's Degree in Microbiology and Public Health.
  • Dr. Berg has been the recipient of many awards during his illustrious career, including the Patients' Choice Award (2017).
  • The doctor has been married to Mrs. Carolyn Berg for 30 years and they have one daughter, Elizabeth.

Report: Physician Starting Salaries Surging After COVID-19

Retrieved on: 
Monday, August 14, 2023
AMN, Certified Registered Nurse Anesthetist, Insurance, PAS, COVID-19, Ageing, Gastroenterology, Pulmonology, Neurology, DSM-IV codes, Crna, Organization, Radiology, Dermatology, Incentive, Hospital, Physician, NPS, Urology, Practitioner, Orthopedic surgery, Oncology, Elective surgery, Annual report, Pediatrics, Anesthesiology, Nursing

The 2023 Review of Physician and Advanced Practitioner Recruiting Incentives indicates that average starting salaries are up 19% year-over-year for psychiatrists, up 16% for dermatologists, up 12.5% for anesthesiologists and up 12% for orthopedic surgeons, with various other types of physicians also seeing starting salary increases.

Key Points: 
  • The 2023 Review of Physician and Advanced Practitioner Recruiting Incentives indicates that average starting salaries are up 19% year-over-year for psychiatrists, up 16% for dermatologists, up 12.5% for anesthesiologists and up 12% for orthopedic surgeons, with various other types of physicians also seeing starting salary increases.
  • Pediatricians are offered the lowest average starting salary of physicians tracked in the report at $233,000.
  • “Rising physician starting salaries are a clear sign that demand for physicians is surging,” said Leah Grant, President of AMN Healthcare Physician Solutions.
  • The remaining 19% were for advanced practice professionals such as nurse practitioners (NPs), physician assistants (PAs), and certified registered nurse anesthetists (CRNAs).